Submit an Original Article

Sarepta Therapeutics Drops on Fake Citron Tweet

From Rumors
January 30, 2013 - 11:37am
Shares of Sarepta Therapeutics (NASDAQ: SRPT) dropped briefly on Wednesday, giving back all their gains on the session, after a tweet from a twitter account called @citronresearc. The tweet states: "$SRPT FDA steps in as its 48 weeks results on Eteplirsen results are ...

Continue reading this article »

Share This Article:

Submit an Original Article

Wall Street Buzz

MOST POPULAR